News Articles

      • 20 May, 2019

    ISSCR Applauds Health Canada’s New Policy Statement re Autologous Cell Therapy Products

    The ISSCR welcomes the new policy guidance from Health Canada that clarifies the regulation of autologous cell products in Canada. The new policy guidance aligns Canada’s regulations with the U.S. Food and Drug Administration’s 2017 Regenerative Medicine Framework and the Australian Therapeutic Goods Administration’s 2018 Autologous human cell and tissue product regulations.
    Full story
      • 13 May, 2019

    The Important Role of Patients

    A wide variety of motivations propel us to pursue science careers at the bench or in industry. Often as young adults we’re driven by curiosity and the desire to understand why things work the way they do. One key motivator for many of us is the potential to have a real impact on the lives of patients and their families.
    Full story
      • 10 May, 2019

    ISSCR Commends U.S. House of Representatives Committee for Approval of NIH Funding Bill

    The Appropriations Committee of the U.S. House of Representatives has approved a $2 billion increase for the National Institutes of Health (NIH) and defeated an amendment that would have prohibited federal funding for fetal tissue research.
    Full story
      • 2 May, 2019

    Stem Cell Therapies and Regenerative Medicine Moving Toward the Clinic

    Stem cell research is leading to potential new therapies to treat disease, with several applications in clinical trials or expected to enter trials in the coming months. These new discoveries are transforming how we think of medicine and will be key to discussions at the International Society for Stem Cell Research annual meeting, 26-29 June at the Los Angeles Convention Center.
    Full story
      • 8 April, 2019

    Guidelines and Regulations Necessary as Stem Cell Field Advances

    With the rapid growth of the stem cell field and advances in regenerative medicine, it is critically important that researchers earn and retain the public trust. To that end we must operate under agreed-upon guidelines that ensure ethical activities, transparency, and sound science.
    Full story
      • 29 March, 2019

    ISSCR Comments on New Biomedical Technology Regulations in China

    In response to draft regulations in China on gene editing and other potentially risky biomedical technologies, the ISSCR has submitted comments to the the country's National Health Commission Medical and Medical Administration Bureau.
    Full story
      • 13 March, 2019

    ISSCR Applauds New Japanese Rules Allowing Human-to-Animal Chimeric Embryo Research

    The ISSCR supports research using human-animal chimeras conducted under appropriate review and oversight (ISSCR Guidelines Recommendation 2.1.5) and applauds the new Japanese rules enabling research on chimeric embryos.
    Full story
      • 11 March, 2019

    ISSCR 2019 Election Results

    ISSCR has elected its next leadership slate, with leaders beginning their terms after the 2019 annual meeting. On behalf of all members, we extend congratulations to newly-elected officers Melissa Little, vice president; and Kenneth Zaret, treasurer, and re-appointed board members Marianne Bronner, Valentina Greco, and Arnold Kriegstein.
    Full story
      • 8 March, 2019

    Sharing Excellent Science and Growing Personal Networks

    Each year our annual ISSCR meeting showcases for the world the potential of stem cell science and advances already underway that are changing the face of human healthcare. We highlight the latest innovative research and scientific developments that are propelling the field forward in a variety of ways. ISSCR 2019 in Los Angeles is a terrific opportunity to inspire us with research at the leading-edge of scientific discovery
    Full story
      • 25 February, 2019

    Progress in Stem Cell Science & Regenerative Medicine On Tap in Los Angeles, 26-29 June

    Top scientists and researchers from academia, medicine, and industry will gather to share groundbreaking stem cell science and its translation to clinical application at the annual meeting of the International Society for Stem Cell Research (ISSCR), 26-29 June in Los Angeles, Calif.
    Full story
      • 22 February, 2019

    Advocating for Science and Research

    Scientists play a critical role in advocating for research that is advancing healthcare and biomedicine. In the February edition of Stem Cell Reports, several ISSCR researchers share their answers to the question 'Why is it important to you to support fetal tissue research?'
    Full story
      • 8 February, 2019

    ISSCR Announces 2019 Award Recipients

    The ISSCR announces the recipients of its 2019 Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award. Awardees will be recognized at the ISSCR annual meeting, 26-29 June, in Los Angeles, Calif., U.S.
    Full story
      • 8 February, 2019

    New Voices, Breakthrough Science at ISSCR 2019

    If you’re an enterprising stem cell scientist with exciting work to publish this year, the ISSCR annual meeting in Los Angeles, 26-29 June, is the place to take the stage and showcase your science to colleagues and the field. We’ve developed a new program structure this year that dedicates 15 plenary speaking spots to abstract-selected speakers, to showcase the talents of the next generation of scientists.
    Full story
      • 21 January, 2019

    ISSCR Introduces Chief Operating Officer Keith Alm

    Keith Alm joined the ISSCR as chief operating officer in January 2019, after serving as a brand strategist and consultant for the society for nearly a decade. He’s worked with many of the organization's leaders on strategic positioning, communications, and partnerships.
    Full story
      • 4 January, 2019

    Standing Up for Scientific Research

    The ISSCR’s support for stem cell science and the field is central to our mission, and we speak up for policies around the world that allow our work to continue and thrive. We also provide background and current understanding about stem cell science to inform decision makers about key issues affecting science and health.
    Full story